FDA Orange Book · active-ingredient family
Tramadol hydrochloride
Tramadol hydrochloride is approved as 6 brand and 34 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:QDOLO · NDA 214044
6
Brand (NDA)
34
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, extended release, solution, tablet, tablet, extended release, tablet, orally disintegrating
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| QDOLORLD | ROSEMONT | NDA 214044 | — | Sep 01, 2020 | |
| CONZIPRLD×4 | CIPHER PHARMS INC | NDA 022370 | — | May 07, 2010 | |
| RYZOLTRLD×3 | PURDUE PHARMA | NDA 021745 | — | Dec 30, 2008 | |
| ULTRAM ERRLD×3 | VALEANT PHARMS | NDA 021692 | — | Sep 08, 2005 | |
| ULTRAMRLD×2 | JANSSEN PHARMS | NDA 020281 | — | Mar 03, 1995 | |
| RYBIX ODT | SHIONOGI INC | NDA 021693 | — | May 05, 2005 |
Generic (ANDA) products (34)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TRAMADOL HYDROCHLORIDE×2 | STRIDES PHARMA | ANDA 202075 | AB | Mar 23, 2026 | |
| TRAMADOL HYDROCHLORIDE×3 | MACLEODS PHARMS LTD | ANDA 209404 | AB1 | Jan 31, 2025 | |
| TRAMADOL HYDROCHLORIDE×4 | RUBICON RESEARCH | ANDA 208708 | AB | Nov 27, 2023 | |
| TRAMADOL HYDROCHLORIDE | UNICHEM | ANDA 211825 | AB | Aug 09, 2019 | |
| TRAMADOL HYDROCHLORIDE | PURACAP LABS BLU | ANDA 206706 | — | Jul 02, 2019 | |
| TRAMADOL HYDROCHLORIDE×3 | MYLAN | ANDA 205257 | — | Dec 22, 2015 | |
| TRAMADOL HYDROCHLORIDE×3 | AUROBINDO PHARMA LTD | ANDA 204421 | — | Oct 20, 2015 | |
| TRAMADOL HYDROCHLORIDE | MACLEODS PHARMS LTD | ANDA 205702 | — | Sep 25, 2015 | |
| TRAMADOL HYDROCHLORIDE | AUROBINDO PHARMA LTD | ANDA 203494 | AB | Mar 31, 2014 | |
| TRAMADOL HYDROCHLORIDE | ACCORD HLTHCARE | ANDA 202390 | — | May 16, 2013 | |
| TRAMADOL HYDROCHLORIDE | CSPC OUYI PHARM CO | ANDA 091498 | AB | Mar 29, 2013 | |
| TRAMADOL HYDROCHLORIDE | IPCA LABS LTD | ANDA 201973 | — | Nov 16, 2012 | |
| TRAMADOL HYDROCHLORIDE×3 | ACTAVIS ELIZABETH | ANDA 091609 | — | Jun 27, 2012 | |
| TRAMADOL HYDROCHLORIDE×3 | PH HEALTH | ANDA 200491 | — | Jun 27, 2012 | |
| TRAMADOL HYDROCHLORIDE×3 | SUN PHARM | ANDA 091607 | — | Dec 30, 2011 | |
| TRAMADOL HYDROCHLORIDE×3 | SUN PHARM | ANDA 201384 | — | Dec 07, 2011 | |
| TRAMADOL HYDROCHLORIDE×3 | LUPIN LTD | ANDA 200503 | AB1 | Aug 29, 2011 | |
| TRAMADOL HYDROCHLORIDE | SENORES PHARMS | ANDA 090404 | AB | Jan 31, 2011 | |
| TRAMADOL HYDROCHLORIDE | NORTHSTAR HLTHCARE | ANDA 078935 | — | May 26, 2010 | |
| TRAMADOL HYDROCHLORIDE×3 | STRIDES PHARMA INTL | ANDA 078783 | — | Nov 13, 2009 | |
| TRAMADOL HYDROCHLORIDE | MYLAN PHARMS INC | ANDA 075980 | — | Nov 21, 2002 | |
| TRAMADOL HYDROCHLORIDE | ASTA | ANDA 075974 | — | Jul 12, 2002 | |
| TRAMADOL HYDROCHLORIDE | APOTEX | ANDA 075981 | — | Jul 10, 2002 | |
| TRAMADOL HYDROCHLORIDE | IVAX SUB TEVA PHARMS | ANDA 075963 | — | Jul 03, 2002 | |
| TRAMADOL HYDROCHLORIDE | PLIVA | ANDA 075982 | — | Jul 01, 2002 | |
| TRAMADOL HYDROCHLORIDE×2 | GRAVITI PHARMS | ANDA 075968 | AB | Jun 25, 2002 | |
| TRAMADOL HYDROCHLORIDE | SPECGX LLC | ANDA 075983 | — | Jun 25, 2002 | |
| TRAMADOL HYDROCHLORIDE | WATSON LABS | ANDA 075962 | — | Jun 24, 2002 | |
| TRAMADOL HYDROCHLORIDE | MYLAN | ANDA 075986 | — | Jun 21, 2002 | |
| TRAMADOL HYDROCHLORIDE | AMNEAL PHARMS | ANDA 076003 | AB | Jun 20, 2002 | |
| TRAMADOL HYDROCHLORIDE | SUN PHARM INDUSTRIES | ANDA 076100 | — | Jun 20, 2002 | |
| TRAMADOL HYDROCHLORIDE | ACTAVIS ELIZABETH | ANDA 075960 | — | Jun 19, 2002 | |
| TRAMADOL HYDROCHLORIDE | SUN PHARM INDS INC | ANDA 075964 | AB | Jun 19, 2002 | |
| TRAMADOL HYDROCHLORIDE | TEVA | ANDA 075977 | AB | Jun 19, 2002 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11103452 | Sep 01, 2040 | in 14 yr 5 mo | ProductU-3197 |
| 11752103 | Sep 01, 2040 | in 14 yr 5 mo | ProductU-3197 |
Tramadol hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

